Legault L, Cernacek P, Levy M, Maher E, Farber D
Department of Physiology, McGill University, Montreal, Quebec, Canada.
J Clin Invest. 1992 Oct;90(4):1425-35. doi: 10.1172/JCI116009.
60% of chronic caval dogs with ascites did not respond to atrial natriuretic peptide (ANP) (75 ng.kg-1.min-1) with a natriuresis (TIVC-NR; delta UNaV = 2 +/- 0.8 mu eq/min) whereas the remaining 40% responded normally (TIVC-R; delta UNaV = 216 +/- 50 mu eq/min). Since proximal tubule neutral endopeptidase 24:11 (NEP) destroys most of intrarenal luminal ANP and kinins, we attempted to convert TIVC-NR into TIVC-R by providing NEP inhibition with SQ 28603 at 30 mg/kg. This potent and specific NEP inhibitor produced a natriuresis when administered alone to nine TIVC-NR dogs (delta UNaV = 67 +/- 2 mu eq/min) and permitted a natriuresis in the presence of ANP (delta UNaV = 97 +/- 18 mu eq/min). A natriuretic response to ANP could also be induced in TIVC-NR dogs by providing renal arterial bradykinin or intravenous captopril, a kininase inhibitor. Urodilatin, a natriuretic peptide not destroyed by intrarenal NEP was without effect in TIVC-NR dogs but increased UNaV when given to TIVC-R and normal dogs. Providing bradykinin to TIVC-NR now permitted an increment in delta UNaV (62 mu eq/min) when urodilatin was reinfused. TIVC-R dogs could be converted into TIVC-NR by pretreating with a specific bradykinin antagonist before infusing ANP. We conclude that TIVC-NR dogs are deficient in intrarenal kinins but are converted to responding dogs after NEP inhibition because of increased kinin delivery to the inner medullary collecting duct.
60%的患有腹水的慢性腔静脉狗对心房利钠肽(ANP)(75 ng·kg⁻¹·min⁻¹)无排钠反应(TIVC-NR;尿钠排泄变化量[ΔUNaV]=2±0.8 μeq/min),而其余40%反应正常(TIVC-R;ΔUNaV=216±50 μeq/min)。由于近端小管中性内肽酶24:11(NEP)可破坏大部分肾内管腔中的ANP和激肽,我们尝试通过给予30 mg/kg的SQ 28603抑制NEP,将TIVC-NR转变为TIVC-R。这种强效且特异性的NEP抑制剂单独给予9只TIVC-NR狗时可产生排钠作用(ΔUNaV=67±2 μeq/min),并在存在ANP时也能实现排钠(ΔUNaV=97±18 μeq/min)。通过给予肾动脉缓激肽或静脉注射卡托普利(一种激肽酶抑制剂),也可在TIVC-NR狗中诱导出对ANP的排钠反应。尿舒张素是一种不被肾内NEP破坏的利钠肽,对TIVC-NR狗无效,但给予TIVC-R狗和正常狗时可增加尿钠排泄量。再次输注尿舒张素时,给TIVC-NR狗提供缓激肽可使ΔUNaV增加(62 μeq/min)。在输注ANP前用特异性缓激肽拮抗剂预处理,可将TIVC-R狗转变为TIVC-NR。我们得出结论,TIVC-NR狗肾内激肽缺乏,但在抑制NEP后转变为有反应的狗,这是因为输送到髓质内集合管的激肽增加。